News

Filter

Current filters:

Avila Therapeutics

More news for ASH meeting

13-12-2011

In continuing news from the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego,…

Avila TherapeuticsGleevecNovartisOncologypacritinibPharmaceuticalResearchS*BIOTasigna

Avila says Clovis selects clinical drug candidate; enters deal with NIAID for HCV candidate

09-06-2011

US biotech company Avila Therapeutics announced that it has achieved a significant goal in its $209 million…

Anti-viralsAvila TherapeuticsBiotechnologyClovis OncologyOncologyPharmaceuticalResearch

Avila scientists find new opportunities for covalent drugs

04-04-2011

Privately-held US biotech firm Avila Therapeutics announced the publication of a scientific review article…

Avila TherapeuticsBiotechnologyPharmaceuticalResearch

Clovis Oncology and Avila Therapeutics enter $209 million partnership for EGFR mutant-selective inhibitor NSCLC candidate

26-05-2010

US anti-cancer drug developer Clovis Oncology has entered into accord with Avila Therapeutics for the…

Avila TherapeuticsBiotechnologyClovis OncologyLicensingOncologyPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top